13th September 2021 | Pharma Updates

Glenmark receives CDSCO approval for Vildagliptin, Metformin and Remogliflozin

India’s drug regulator has given nod to Glenmark to manufacture and market Vildagliptin, Metformin and Remogliflozin.

Jubilant Cadista, Granules India recall different products in the United States market

According to the report by FDA, Granules India is recalling more than 1.14 cr Naproxen Sodium tablets.

Shoolini University breaks into the Top 100 University league

Himachal based 12 yr old Shoolini University has been ranked among the Top 100 Universities in India by GOI’s NIRF.

ZyCoV-D likely to be launched next month

Zydus Cadila’s has received the approval for its Covid vaccine on August 2 2021.

Drug store set up at UP’s Gurudwara

In Kanpur a pharmacy store has been set up at Gurudwara, which will provide medicines to the needy at affordable rates.

New biotech Joint Venture in Cuba offers scope for Indian drug companies: Pharmexcil

A new joint venture established in Cuba is offering opportunities to Indian drug and biotech companies for investments and associations.

Goods and Services Tax Council may allow intra-state pharma cess, discuss states' dues

It may discuss extending the compensation cess for states beyond 2022.